Chicago Question DeskA notebook for peptide questions
Caution notes · compounding

What about a medicine made to order?

Ask why that exact medicine needs to be made to order.

When a medicine is prepared to order, the process is called compounding. Checking the medicine is a separate step from checking the person treating you. Check the person prescribing, the pharmacy and the medicine.

Jump to an answer

Why might compounding come up?

Compounding can address a need such as a dye allergy or trouble swallowing a tablet.

The Food and Drug Administration (FDA) is the federal drug agency.

FDA does not approve medicines made to order. FDA does not check these medicines for safety, quality or how well they work before they go on sale.

Ask what need a ready-made product would leave unmet. Ask which pharmacy makes the medicine and how to speak with its pharmacist.

Ask about any claimed exception

If someone says a prescription is not needed, ask the pharmacist to show which part of the rule permits that for your medicine.

Can a pharmacy simply copy a ready-made drug?

Federal law limits how often pharmacies can make copies of drugs already available.

The prescriber can explain how a change to the medicine makes an important difference for you.

A price reduction by itself does not satisfy this rule.

On September 26, 2026, semaglutide injections (Ozempic, Wegovy) and tirzepatide injections (Mounjaro, Zepbound) were not on FDA’s national drug shortage list.

One local pharmacy running out does not mean FDA has listed a national shortage.

FDA may still treat a medicine made to order as a copy of an available drug even if a vitamin has been added. Adding the vitamin does not by itself avoid the rules that limit making copies.

Have the prescriber explain why you need the change and which rule permits it. A lower price does not answer that question.

What if the name is BPC-157 or retatrutide?

A search of FDA’s approval records on September 26, 2026, found no approved US medicine containing BPC-157, ipamorelin or retatrutide.

FDA says pharmacies cannot legally make medicines with retatrutide or cagrilintide under federal law.

BPC-157 and ipamorelin acetate appear on FDA’s list of ingredients whose requests were withdrawn. This means the people asking FDA to allow those ingredients took back their requests.

Taking back a request does not mean FDA approved the ingredient or gave permission to make medicines with it.

Ask for the exact ingredient and whether it would be a tablet, injection or another form. Ask what rule permits that pharmacy to prepare the medicine. Check each ingredient by name.